• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基质金属蛋白酶及其组织抑制剂在中国胰腺癌中的表达及其局部侵袭和转移情况

Expression of matrix metalloproteinases and the tissue inhibitors of metalloproteinases and their local invasiveness and metastasis in Chinese human pancreatic cancer.

作者信息

Gong Y L, Xu G M, Huang W D, Chen L B

机构信息

Department of Medical Oncology, Jinling Hospital, Clinical School of Medical College, Nanjing University, Nanjing, P.R. China.

出版信息

J Surg Oncol. 2000 Feb;73(2):95-9. doi: 10.1002/(sici)1096-9098(200002)73:2<95::aid-jso7>3.0.co;2-r.

DOI:10.1002/(sici)1096-9098(200002)73:2<95::aid-jso7>3.0.co;2-r
PMID:10694645
Abstract

BACKGROUND AND OBJECTIVES

The objective was to evaluate the potent role of matrix metalloproteinases(MMPs) and the tissue inhibitors of metalloproteinases(TIMPs) in processes leading to metastasis and local invasiveness of Chinese human ductal adenocarcinomas of the pancreas. We also evaluated a possible biological association between the gene expression and clinical manifestations.

METHODS

Northern blot and in situ hybridization have shown MMP and TIMP gene expression in the pancreas and alterations associated with neoplastic transformation. Fifteen cases of surgical pancreatic specimens were examined, using cDNA probes to MMP2, MMP9, and TIMP1. Findings were correlated with the size of tumor section, CA19-9, pathological classification, thrombosis, and infiltration of capsule and lymphonoids.

RESULTS

Increased levels of the mRNA of MMP2, MMP9, and TIMP1 genes, MMP2 approximately MMP9<TIMP1, were found in pancreatic cancer tissues examined. Low levels of transcripts for MMP2, MMP9, and TIMP1 were detectable in pancreata of organ donors. Transcripts coding for MMP2, MMP9, and TIMP1 were found in both stroma and tumor cells. However, gene expression of MMP2, MMP9, and TIMP1 has shown an obvious correlation with the infiltration of capsule cells, surrounding lymphonoids and specific histopathological features.

CONCLUSIONS

We concluded that the imbalance between MMPs and TIMPs may help physicians to assess the metastatic potential and then tell the prognosis of individual patients.

摘要

背景与目的

本研究旨在评估基质金属蛋白酶(MMPs)及其组织抑制剂(TIMPs)在中国胰腺癌导管腺癌转移和局部侵袭过程中的重要作用。我们还评估了基因表达与临床表现之间可能存在的生物学关联。

方法

Northern印迹法和原位杂交法已显示MMP和TIMP基因在胰腺中的表达以及与肿瘤转化相关的改变。使用针对MMP2、MMP9和TIMP1的cDNA探针,对15例手术切除的胰腺标本进行检测。研究结果与肿瘤切片大小、CA19-9、病理分类、血栓形成以及包膜和淋巴结浸润情况相关联。

结果

在所检测的胰腺癌组织中发现MMP2、MMP9和TIMP1基因的mRNA水平升高,MMP2约等于MMP9<TIMP1。在器官捐献者的胰腺中可检测到低水平的MMP2、MMP9和TIMP1转录本。在基质和肿瘤细胞中均发现了编码MMP2、MMP9和TIMP1的转录本。然而,MMP2、MMP9和TIMP1的基因表达与包膜细胞浸润、周围淋巴结以及特定组织病理学特征之间存在明显相关性。

结论

我们得出结论,MMPs与TIMPs之间的失衡可能有助于医生评估转移潜能,进而判断个体患者的预后。

相似文献

1
Expression of matrix metalloproteinases and the tissue inhibitors of metalloproteinases and their local invasiveness and metastasis in Chinese human pancreatic cancer.基质金属蛋白酶及其组织抑制剂在中国胰腺癌中的表达及其局部侵袭和转移情况
J Surg Oncol. 2000 Feb;73(2):95-9. doi: 10.1002/(sici)1096-9098(200002)73:2<95::aid-jso7>3.0.co;2-r.
2
Imbalance of expression of matrix metalloproteinases (MMPs) and tissue inhibitors of the matrix metalloproteinases (TIMPs) in human pancreatic carcinoma.人类胰腺癌中基质金属蛋白酶(MMPs)与基质金属蛋白酶组织抑制剂(TIMPs)表达失衡
J Pathol. 1997 Jul;182(3):347-55. doi: 10.1002/(SICI)1096-9896(199707)182:3<347::AID-PATH848>3.0.CO;2-J.
3
In situ gene expression and localization of metalloproteinases MMP1, MMP2, MMP3, MMP9, and their inhibitors TIMP1 and TIMP2 in human renal cell carcinoma.金属蛋白酶MMP1、MMP2、MMP3、MMP9及其抑制剂TIMP1和TIMP2在人肾细胞癌中的原位基因表达及定位
Oncol Rep. 2006 May;15(5):1379-84.
4
Matrix metalloproteinases MMP1, MMP2, MMP9 and their tissue inhibitors TIMP1, TIMP2, TIMP3 in head and neck cancer: an immunohistochemical study.头颈部癌中基质金属蛋白酶MMP1、MMP2、MMP9及其组织抑制剂TIMP1、TIMP2、TIMP3的免疫组织化学研究
Otolaryngol Pol. 2016 Jun 30;70(3):32-43. doi: 10.5604/00306657.1202546.
5
Expression of MMP and TIMP mRNA in peripheral blood leukocytes of patients with invasive ductal carcinoma of the breast.乳腺浸润性导管癌患者外周血白细胞中MMP和TIMP mRNA的表达
Int J Biol Markers. 2016 Jul 30;31(3):e309-16. doi: 10.5301/jbm.5000203.
6
Rat pancreatic stellate cells secrete matrix metalloproteinases: implications for extracellular matrix turnover.大鼠胰腺星状细胞分泌基质金属蛋白酶:对细胞外基质周转的影响。
Gut. 2003 Feb;52(2):275-82. doi: 10.1136/gut.52.2.275.
7
Expression of MMP2, MMP9, MT1-MMP, TIMP1, and TIMP2 mRNA in valvular lesions of the heart.MMP2、MMP9、MT1-MMP、TIMP1和TIMP2 mRNA在心脏瓣膜病变中的表达。
J Pathol. 2001 Jun;194(2):225-31. doi: 10.1002/path.850.
8
Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human pancreatic adenocarcinomas: clinicopathologic and prognostic significance of matrilysin expression.基质金属蛋白酶及其组织抑制剂在人胰腺腺癌中的表达:基质溶素表达的临床病理及预后意义
J Clin Oncol. 2001 Feb 15;19(4):1118-27. doi: 10.1200/JCO.2001.19.4.1118.
9
Elevated ratio of MMP2/MMP9 activity is associated with poor response to chemotherapy in osteosarcoma.MMP2/MMP9活性比值升高与骨肉瘤化疗反应不佳相关。
BMC Cancer. 2016 Mar 15;16:223. doi: 10.1186/s12885-016-2266-5.
10
A role for matrix metalloproteinases and tumor host interaction in hepatocellular carcinomas.基质金属蛋白酶和肿瘤宿主相互作用在肝细胞癌中的作用。
Am J Surg. 2002 May;183(5):588-94. doi: 10.1016/s0002-9610(02)00833-4.

引用本文的文献

1
Elevated systemic levels of the matrix metalloproteinase inhibitor TIMP-1 correlate with clinical markers of cachexia in patients with chronic pancreatitis and pancreatic cancer.基质金属蛋白酶抑制剂 TIMP-1 的系统水平升高与慢性胰腺炎和胰腺癌患者的恶病质临床标志物相关。
BMC Cancer. 2018 Feb 2;18(1):128. doi: 10.1186/s12885-018-4055-9.
2
Prognostic significance of plasma matrix metalloprotease-2 in pancreatic cancer patients.血浆基质金属蛋白酶-2 在胰腺癌患者中的预后意义。
Indian J Med Res. 2017 Sep;146(3):334-340. doi: 10.4103/ijmr.IJMR_1348_15.
3
Sequential Validation of Blood-Based Protein Biomarker Candidates for Early-Stage Pancreatic Cancer.
早期胰腺癌血液中蛋白质生物标志物候选物的序贯验证
J Natl Cancer Inst. 2017 Apr 1;109(4). doi: 10.1093/jnci/djw266.
4
Role of MMP-2 (-1306 C/T) Polymorphism in Pituitary Adenoma.基质金属蛋白酶-2(-1306 C/T)多态性在垂体腺瘤中的作用
Scientifica (Cairo). 2016;2016:2839697. doi: 10.1155/2016/2839697. Epub 2016 Mar 9.
5
miR-221/222 induces pancreatic cancer progression through the regulation of matrix metalloproteinases.微小RNA-221/222通过调控基质金属蛋白酶诱导胰腺癌进展。
Oncotarget. 2015 Jun 10;6(16):14153-64. doi: 10.18632/oncotarget.3686.
6
Prognostic impact of a compartment-specific angiogenic marker profile in patients with pancreatic cancer.特定区域血管生成标志物谱对胰腺癌患者的预后影响
Oncotarget. 2014 Dec 30;5(24):12978-89. doi: 10.18632/oncotarget.2651.
7
Chlorotoxin-Fc fusion inhibits release of MMP-2 from pancreatic cancer cells.氯毒素-Fc融合蛋白抑制胰腺癌细胞中MMP-2的释放。
Biomed Res Int. 2014;2014:152659. doi: 10.1155/2014/152659. Epub 2014 Jan 6.
8
Expression of lysophosphatidic acid receptors and local invasiveness and metastasis in Chinese pancreatic cancers.中文胰腺癌中溶血磷脂酸受体的表达与局部侵袭和转移。
Curr Oncol. 2012 Jul;19(Suppl 2):eS15-21. doi: 10.3747/co.19.1138.
9
Effect of shRNA targeting survivin on ovarian cancer.Survivin 靶向短发夹 RNA 对卵巢癌的影响。
J Cancer Res Clin Oncol. 2012 Jul;138(7):1221-9. doi: 10.1007/s00432-012-1196-0. Epub 2012 Mar 18.
10
Retinoid signaling in pancreatic cancer, injury and regeneration.视黄酸信号在胰腺癌、损伤和再生中的作用。
PLoS One. 2011;6(12):e29075. doi: 10.1371/journal.pone.0029075. Epub 2011 Dec 29.